Transfection complexes
US8026341B2 · kind B2 · utility
3Cited by
2References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 16, 2010 |
| Grant date | Sep 27, 2011 |
| Priority date | — |
| Expiry date | Mar 16, 2030 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2500/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides a peptide having at least 3 amino acids comprising an amino acid sequence selected fromin which X1 is a basic amino acid residue, X2 is Q or P, X3 is A or T, X4 is an acidic amino acid residue and X5 is P or Q.The invention further provides non-viral cell-targeting vector complexes and methods associated therewith.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.